NICE: Roche's Tarceva too expensive for maintenance therapy of NSCLC

18.06.10 London – UK's National Institute for Clinical Excellence (NICE) has provisionally refused to approve Tarceva (erlotinib) as a maintenance treatment for NHS patients in England and Wales who have non-small cell lung cancer... more

New therapy offers hope to spinal muscular atrophy patients

10.06.10 Sheffield – UK researchers at the University of Sheffield have presented a new approach to treat children who suffer from the devastating disease Spinal Muscular Atrophy (Science Translational Medicine, 9 June). Using a novel... more

UK researchers find out that stem cells do not exist

26.05.10 Edinburgh - UK researchers have provided the first evidence that embryonic stem cells are not a single cell type in vivo as previously thought, but comprise a mixture of different cell types from the early embryo, that can... more

Cytokine reduces sepsis mortality in mice

17.05.10 Glasgow – UK researchers have determined that cytokine IL-33 significantly reduces mortality from sepsis, a systemic inflammation that often follows bacterial infection with, until now, limited therapeutic options (Nature... more

Early Alteplase treatment provides better outcomes after stroke

14.05.10 Glasgow – New clinical data suggest that after a stroke, the thrombolytic drug alteplase needs to be given as soon as possible. Pooled clinical data from 3,670 patients suggest for the first time that short-term survival is... more